The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may reduce the efficacy of the current line of vaccines, scientists said.
Researchers are racing to establish whether the vaccines currently being rolled out across the globe are effective against the so-called 501Y.V2 variant, identified by South African genomics experts late last year in Nelson Mandela Bay.
The 501Y.V2 variant is 50 per cent more infectious than previous ones, South African researchers said this week. It has already spread to at least 20 countries since being reported to the World Health Organisation in December.
It is one of several new variants discovered recently.
British scientists and politicians have expressed concern that vaccines currently being deployed or in development could be less effective against the variant.
YOU SHOULD NOT MISS THESE HEADLINES FROM NIGERIAN TRIBUNE
Last week, Nigeria recorded 70 new COVID-19 deaths which is the highest in six months, Tribune Online analysis reveals.
According to data sourced from the Nigeria Centre for Disease Control (NCDC), the last time Nigeria recorded more deaths than last week was the 78 deaths reported in the 30th week of the pandemic (July 19 – July 25)…
Joe Biden has been sworn in as the President of the United States. He did so at exactly 5:48 pm Nigerian time. Biden is the 46th president of the United States. The oath was administered by Justice John G. Roberts, Jr…
NATIONAL coordinator of the Presidential Task Force (PTF) on COVID-19, Dr Sani Aliyu, has said the nation is expected to receive its first batch of the COVID-19 vaccines by the end of this month.
Aliyu made the disclosure as a guest on ARISE News, on Sunday. Upon receipt of the vaccines, Aliyu said vaccination of the public, especially those that are vulnerable, the elderly…
New COVID-19 variant may reduce vaccine efficacy